Shri Dinesh Mills Ltd

📊 Shri Dinesh Mills Q1 FY2025 Financial Snapshot: Key Figures & Subsidiary Performance

- Submitted unaudited standalone & consolidated financial results for June 30, 2025 quarter.

- Board approved results on August 5, 2025 after Audit Committee review.

- Consolidated results include subsidiaries Dinesh Remedies, Fernway Technologies, Stellent Chemicals, and associate McGean India Chemicals.

- Auditors R.K. Doshi & Co. LLP issued clean review report with no material misstatements.

- Subsidiaries' combined revenue: Rs. 18.67 lakhs (unaudited).

- Group's share of profit from McGean India Chemicals: Rs. 28.64 lakhs.

- Subsidiaries' net profit: Rs. 1.76 lakhs (unaudited but deemed immaterial to group).

- Figures aligned with Ind AS 34 standards and SEBI regulations.